{"id":23856,"date":"2012-12-07T12:51:17","date_gmt":"2012-12-07T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23856"},"modified":"2018-04-14T02:08:34","modified_gmt":"2018-04-14T07:08:34","slug":"23856","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/23856\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 7 de dezembro de 2012"},"content":{"rendered":"

vers\u00e3o para impress\u00e3o<\/a><\/p>\n

***********************************
\nBrakke Consulting's
\nNot\u00edcias e notas de sa\u00fade animal de 7 de dezembro de 2012
\n<\/strong>Copyright \u00a9 Brakke Consulting, Inc.
\n 
\nEditor: Lynn Fondon DVM MBA
\n************************************
\nNAS NOTICIAS:
\n 
\nNovidades da Brakke Consulting
\n<\/u>Nova marca corporativa
\n 
\nnot\u00edcias de ganhos
\n<\/u>DS Pharma
\n 
\noutras not\u00edcias
\n<\/u>Anacor Farmac\u00eautica
\nAratana Terap\u00eautica
\nCalpis
\nElanco
\nninhada da sorte
\nMerial
\nPacira
\nMelhor seguro para animais de estima\u00e7\u00e3o
\nPfizer
\nSistemas de R\u00e1dio
\nSmartPak
\nSimbi\u00f3ticos
\n 
\n***********************************
\nBRAKKE CONSULTING, INC.
\nBRAKKE LAN\u00c7A UM NOVO VISUAL
\n<\/strong> 
\nA Brakke Consulting tem um novo visual corporativo para acompanhar sua expans\u00e3o em novos mercados na ind\u00fastria de sa\u00fade animal. Al\u00e9m do novo visual, a Brakke ampliou e aprimorou suas ferramentas de comunica\u00e7\u00e3o para que a empresa continue prestando uma consultoria de qualidade e auxiliando os clientes na compreens\u00e3o da ampla gama de servi\u00e7os \u00e0 sua disposi\u00e7\u00e3o.
\n 
\nwww.BrakkeConsulting.com<\/a>
\n 
\n***********************************
\nRELEASES DE RESULTADOS DA EMPRESA
\n 
\n> DS Pharma Animal Health Company reportou resultados para o primeiro semestre de 2012 encerrado em 30 de setembro de 2012. A empresa reportou receita de Y5.700 milh\u00f5es ($71 milh\u00f5es), um aumento de 2% em compara\u00e7\u00e3o com o mesmo per\u00edodo de 2011. Embora as vendas l\u00edquidas de produtos de animais de companhia tenham aumentado 2%, as vendas de produtos de animais de fazenda e aquicultura permaneceram est\u00e1ticas em compara\u00e7\u00e3o com o primeiro semestre de 2011. (comunica\u00e7\u00e3o da empresa)
\n 
\n************************************
\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA
\n 
\n> A Pfizer Animal Health e sua subsidi\u00e1ria Synbiotics anunciaram que agora oferecem armazenamento e envio de s\u00eamen congelado equino. A equipe da Synbiotics preserva e envia ativos caninos de suas instala\u00e7\u00f5es aprovadas pela AKC h\u00e1 mais de 20 anos. (AQHA.com)
\n 
\n> A Merial introduziu o Longrange (eprinomectina), o primeiro verm\u00edfugo injet\u00e1vel de libera\u00e7\u00e3o prolongada para gado que fornece aos produtores de gado controle de parasitas persistentes durante toda a temporada por 100 a 150 dias em uma \u00fanica dose. O controle persistente de parasitas de Longrange por toda a temporada \u00e9 poss\u00edvel devido \u00e0 exclusiva Tecnologia Theraphase, que libera o ingrediente ativo em Longrange por pelo menos 100 dias. (comunicado de imprensa da empresa)
\n 
\n> A Anacor Pharmaceuticals anunciou que alcan\u00e7ou seu segundo candidato de desenvolvimento em sua colabora\u00e7\u00e3o de sa\u00fade animal com a Eli Lilly and Company (Elanco). A colabora\u00e7\u00e3o de pesquisa da Anacor com a Lilly est\u00e1 focada no uso da qu\u00edmica de boro da Anacor para descobrir produtos para uma variedade de aplica\u00e7\u00f5es de sa\u00fade animal. (TheStreet.com)
\n 
\n> A Pacira Pharmaceuticals Inc. anunciou que a Aratana Therapeutics desenvolver\u00e1 uma vers\u00e3o de seu medicamento para dor cir\u00fargica Exparel (lipossoma de bupivaca\u00edna) para uso em procedimentos veterin\u00e1rios. Pacira receber\u00e1 adiantado $1 milh\u00f5es de Aratana, e pode chegar a $42,5 milh\u00f5es em pagamentos de marcos. A empresa tamb\u00e9m receber\u00e1 pagamentos de royalties de mais de 10% sobre as vendas l\u00edquidas. (BusinessWeek.com)
\n 
\n> A Calpis anunciou que investir\u00e1 Y1,5 bilh\u00e3o ($18,75 milh\u00f5es) na constru\u00e7\u00e3o de uma nova f\u00e1brica e laborat\u00f3rio de pesquisa para Calsporin, seu aditivo alimentar probi\u00f3tico, na Ge\u00f3rgia. A f\u00e1brica e o laborat\u00f3rio fabricar\u00e3o 720 toneladas de aditivo alimentar Calsporin a cada ano. Calsporin \u00e9 fabricado atrav\u00e9s da fermenta\u00e7\u00e3o de Bacillus subtilis C-3102. (Farm\u00e1cia Animal)
\n 
\n> Pets Best Insurance anunciou o lan\u00e7amento de um plano de seguro Cancer Only. O plano Cancer Only de baixo custo oferece cobertura para o diagn\u00f3stico e tratamento de c\u00e2nceres malignos, incluindo quimioterapia, resson\u00e2ncia magn\u00e9tica, exames, exames de sangue, cirurgias, medicamentos e outras despesas relacionadas ao c\u00e2ncer. (comunicado de imprensa da empresa)
\n 
\n> A SmartPak anunciou o lan\u00e7amento do ColiCare, um novo programa de bem-estar equino que oferece aos propriet\u00e1rios de cavalos at\u00e9 $7.500 de reembolso caso seu cavalo necessite de cirurgia de c\u00f3lica. Os cavalos que recebem a f\u00f3rmula de sa\u00fade gastrointestinal do SmartPak, SmartDigest Ultra, no Sistema de Alimenta\u00e7\u00e3o Suplementar SmartPak e t\u00eam entre 5 meses e 25 anos de idade s\u00e3o eleg\u00edveis para serem inscritos neste programa. (comunicado de imprensa da empresa)
\n 
\n> A Radio Systems Corporation anunciou a aquisi\u00e7\u00e3o da Lucky Litter LLC, fabricantes das inovadoras caixas de areia e cartuchos ScoopFree e do brinquedo FroliCat para animais de estima\u00e7\u00e3o. Os termos financeiros n\u00e3o foram divulgados. (Corre\u00e7\u00e3o Comercial)
\n 
\n***********************************
\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL
\n 
\n> Reino Unido \u2013 TUBERCULOSE BOVINA Dados publicados pelo Departamento de Meio Ambiente, Alimentos e Assuntos Rurais (Defra) do Reino Unido mostram que o n\u00famero de bovinos infectados com tuberculose bovina abatidos no Reino Unido cresceu pelo terceiro ano consecutivo. A not\u00edcia veio quando o instituto Wellcome Trust publicou a primeira evid\u00eancia direta ligando a infec\u00e7\u00e3o por TB em bovinos com popula\u00e7\u00f5es locais de texugos. (Farm\u00e1cia Animal)
\n 
\n> Reino Unido \u2013 C\u00c2NCER O UK Animal Health Trust (AHT) anunciou a abertura de um centro de tratamento de c\u00e2ncer para c\u00e3es, gatos e cavalos. O AHT Kennel Club Cancer Center em Newmarket abriga um acelerador linear e uma m\u00e1quina de braquiterapia usada no tratamento de radioterapia, juntamente com um tom\u00f3grafo de 16 cortes para auxiliar no planejamento da radioterapia. A AHT acredita que esta \u00e9 a primeira instala\u00e7\u00e3o desse tipo na Europa, constru\u00edda especificamente para tratar cavalos, c\u00e3es e gatos com c\u00e2ncer. (Farm\u00e1cia Animal)
\n 
\n> UE \u2013 PREVEN\u00c7\u00c3O DE DOEN\u00c7AS ANIMAIS A UE destinou mais de 199 milh\u00f5es de euros ($259 milh\u00f5es) para apoiar 137 programas de erradica\u00e7\u00e3o, controle e monitoramento de doen\u00e7as animais e zoonoses, com o objetivo de fortalecer ainda mais a prote\u00e7\u00e3o da sa\u00fade humana e animal em 2013. (ThePigSite.com) 
\n 
\n***********************************
\nPONTO DE VISTA DA BRAKKE CONSULTORIA
\n 
\n\u00c0 medida que fechamos 2012 e analisamos os resultados e as tend\u00eancias para o ano, fica cada vez mais \u00f3bvio que alguns donos de animais de estima\u00e7\u00e3o est\u00e3o migrando para o lado OTC do neg\u00f3cio para comprar determinados produtos. N\u00e3o \u00e9 uma revolu\u00e7\u00e3o; \u00e9 mais uma evolu\u00e7\u00e3o, mas se continuar, vai corroer as quotas de mercado do canal veterin\u00e1rio. Alguns relat\u00f3rios e estudos recentes publicados indicam que os donos de animais preferem conveni\u00eancia e pre\u00e7o ao tomar decis\u00f5es de compra em v\u00e1rias categorias de produtos. As m\u00faltiplas fontes dispon\u00edveis hoje para os donos de animais de estima\u00e7\u00e3o comprarem produtos para seus animais de estima\u00e7\u00e3o continuam a crescer e acreditamos que continuar\u00e3o nos pr\u00f3ximos anos. \u00c9 preciso inova\u00e7\u00e3o e servi\u00e7o superior para reverter h\u00e1bitos de comportamento de compra.<\/p>\n

Esperamos que voc\u00ea tenha notado anteriormente no boletim informativo que a Brakke Consulting est\u00e1 exibindo alguns novos gr\u00e1ficos e ve\u00edculos de comunica\u00e7\u00e3o aprimorados para interagir com nossos clientes atuais e futuros. Esperamos que voc\u00ea ache essas mudan\u00e7as ben\u00e9ficas ao explorar os servi\u00e7os de consultoria que oferecemos ao setor. Voc\u00ea pode visitar nosso site para ver algumas dessas mudan\u00e7as em a\u00e7\u00e3o.
\n 
\nRon Brakke
\n 
\n**********************************
\nEste boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.
\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.
\nPara obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em www.brakkeconsulting.com<\/a>.
\n 
\nBrakke Consulting, Inc.
\n12005 Ford Rd., Suite 530
\nDallas, TX 75234 EUA<\/p>","protected":false},"excerpt":{"rendered":"

vers\u00e3o para impress\u00e3o *********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 7 de dezembro de 2012 Direitos autorais \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon DVM MBA ************************************ IN AS NOT\u00cdCIAS: Not\u00edcias da Brakke Consulting Not\u00edcias sobre ganhos de novas marcas corporativas DS Pharma outras not\u00edcias Anacor Pharmaceuticals Aratana Therapeutics Calpis Elanco Lucky Ninhada Merial Pacira Animais de estima\u00e7\u00e3o Melhor seguro Pfizer Radio Systems SmartPak Synbiotics ***************** ****************** BRAKKE CONSULTING, INC. BRAKKE LAN\u00c7A UM NOVO VISUAL A Brakke Consulting tem um novo visual corporativo para corresponder \u00e0 sua expans\u00e3o em novos mercados na ind\u00fastria de sa\u00fade animal. Al\u00e9m do novo visual, a Brakke ampliou e aprimorou suas ferramentas de comunica\u00e7\u00e3o para que a empresa possa continuar prestando consultoria de qualidade e auxiliando os clientes na compreens\u00e3o da ampla gama de servi\u00e7os \u00e0 sua disposi\u00e7\u00e3o. www.BrakkeConsulting.com *********************************** DIVULGA\u00c7\u00d5ES DE GANHOS DA EMPRESA> DS Pharma Animal Health Company informou resultados do primeiro semestre de 2012 encerrado em 30 de setembro de 2012. A empresa relatou receita de Y5.700 milh\u00f5es ($71 milh\u00f5es), um aumento de 2% em compara\u00e7\u00e3o com o mesmo per\u00edodo de 2011. Embora as vendas l\u00edquidas de produtos para animais de companhia tenham aumentado 2%, fazenda as vendas de produtos de origem animal e de aquicultura permaneceram est\u00e1ticas em rela\u00e7\u00e3o ao primeiro semestre de 2011. (comunica\u00e7\u00e3o da empresa) ******************************* ***** NOT\u00cdCIAS DA EMPRESA > A Pfizer Animal Health e sua subsidi\u00e1ria Synbiotics anunciaram que<\/p>\n

Ver postagem completa<\/a><\/div>\n

;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23856","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/23856\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version *********************************** Brakke Consulting’s Animal Health News & Notes for December 7, 2012 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS:   Brakke Consulting news New corporate brand   earnings news DS Pharma   other news Anacor Pharmaceuticals Aratana Therapeutics Calpis Elanco Lucky Litter Merial Pacira Pets Best Insurance Pfizer Radio Systems SmartPak Synbiotics   *********************************** BRAKKE CONSULTING, INC. BRAKKE ROLLS OUT A NEW LOOK   Brakke Consulting has a new corporate look to match its expansion into new markets in the animal health industry. In addition to the new look, Brakke has increased and improved its communication tools so that the company can continue to provide quality consulting and assist clients in understanding the wide range of services available to them.   www.BrakkeConsulting.com   *********************************** COMPANY EARNINGS RELEASES   > DS Pharma Animal Health Company reported results for the first half of 2012 ended September 30, 2012. The company reported revenue of Y5,700 million ($71 million) , an increase of 2% compared to the same period of 2011. Although net sales of companion animal products increased 2%, farm animal and aquaculture products sales were static compared to the first half of 2011. (company communication)   ************************************ COMPANY NEWS RELEASES   > Pfizer Animal Health and its subsidiary Synbiotics announced thatView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/23856\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2012-12-07T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:08:34+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23856\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23856\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News & Notes for December 7, 2012\",\"datePublished\":\"2012-12-07T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:08:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23856\/\"},\"wordCount\":1068,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23856\/\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/23856\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2012-12-07T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:08:34+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23856\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/pt\/23856\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/23856\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News & Notes for December 7, 2012\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/23856\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version *********************************** Brakke Consulting’s Animal Health News & Notes for December 7, 2012 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS:   Brakke Consulting news New corporate brand   earnings news DS Pharma   other news Anacor Pharmaceuticals Aratana Therapeutics Calpis Elanco Lucky Litter Merial Pacira Pets Best Insurance Pfizer Radio Systems SmartPak Synbiotics   *********************************** BRAKKE CONSULTING, INC. BRAKKE ROLLS OUT A NEW LOOK   Brakke Consulting has a new corporate look to match its expansion into new markets in the animal health industry. In addition to the new look, Brakke has increased and improved its communication tools so that the company can continue to provide quality consulting and assist clients in understanding the wide range of services available to them.   www.BrakkeConsulting.com   *********************************** COMPANY EARNINGS RELEASES   > DS Pharma Animal Health Company reported results for the first half of 2012 ended September 30, 2012. The company reported revenue of Y5,700 million ($71 million) , an increase of 2% compared to the same period of 2011. Although net sales of companion animal products increased 2%, farm animal and aquaculture products sales were static compared to the first half of 2011. (company communication)   ************************************ COMPANY NEWS RELEASES   > Pfizer Animal Health and its subsidiary Synbiotics announced thatView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/23856\/","og_site_name":"Brakke Consulting Website","article_published_time":"2012-12-07T18:51:17+00:00","article_modified_time":"2018-04-14T07:08:34+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/pt\/23856\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/pt\/23856\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News & Notes for December 7, 2012","datePublished":"2012-12-07T18:51:17+00:00","dateModified":"2018-04-14T07:08:34+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/pt\/23856\/"},"wordCount":1068,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/pt\/23856\/","url":"https:\/\/brakkeconsulting.com\/pt\/23856\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2012-12-07T18:51:17+00:00","dateModified":"2018-04-14T07:08:34+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/pt\/23856\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/pt\/23856\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/pt\/23856\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News & Notes for December 7, 2012"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=23856"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23856\/revisions"}],"predecessor-version":[{"id":25373,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23856\/revisions\/25373"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=23856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=23856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=23856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}